Hillhouse Leads USD160m Series B for Chinese Biopharma Genor

Hillhouse Capital led a USD160m Series B for China-based biopharmaceutical company Genor Biopharma, with participation from Temasek Holdings, Haitong Capital, Cavenham PE, and CR-CP Life Science Fund, a joint venture between China Resources Group and Thailand’s Charoen Pokphand Group. Read more… Read More

Carlyle’s Africa Team Spins out to Form Alterra Partners

The Carlyle Group is spinning out its Africa-focused senior executive team to set up Alterra Partners, an independent buyout firm. Alterra will manage Carlyle’s USD698m Sub-Saharan Africa fund as a sub-advisor and will continue to invest with Carlyle’s international energy fund on the continent. Carlyle will hold no… Read More



(default archive template)